{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:29:39Z","timestamp":1779193779723,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1136\/ijgc-2020-001950","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T17:05:31Z","timestamp":1604077531000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Jacek P","family":"Grabowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Glajzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Plett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-9429","authenticated-orcid":false,"given":"Mustafa-Zelal","family":"Muallem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Ioana","family":"Braicu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Taube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001950_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2020-001950_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/ijgc-2020-001950_bb0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygyno.2016.06.023","article-title":"Serous ovarian and primary peritoneal cancers: a comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome","volume":"142","author":"Gao","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2016.08.320","article-title":"Low-grade serous ovarian cancer: a review","volume":"143","author":"Kaldawy","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0030","first-page":"3","article-title":"Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential","volume":"99","author":"Crispens","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001950_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2016.01.022","article-title":"Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase","volume":"140","author":"Grabowski","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0040","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1245\/s10434-017-5919-y","article-title":"Patterns of lymph node metastases in apparent stage I low-grade epithelial ovarian cancer: a multicenter study","volume":"24","author":"Minig","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/gyno.1995.1058","article-title":"Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer--therapeutic advance or surgical folly?","volume":"56","author":"Hacker","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/AOG.0000000000001867","article-title":"Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer","volume":"129","author":"Gockley","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001950_bb0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jnci\/dji102","article-title":"Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial","volume":"97","author":"Panici","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2020-001950_bb0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2020-001950_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001950_bb0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/IGC.0000000000000787","article-title":"Incidence of lymph node metastases in apparent early-stage low-grade epithelial ovarian cancer: a comprehensive review","volume":"26","author":"Lago","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001950_bb0075","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.21873\/anticanres.13757","article-title":"Incidence and pattern of spread of lymph node metastasis in patients with low-grade serous ovarian cancer","volume":"39","author":"Wafa","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2020-001950_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.suronc.2010.08.006","article-title":"Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery","volume":"21","author":"Grabowski","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.humpath.2018.10.020","article-title":"Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the tumor bank ovarian cancer network","volume":"85","author":"Sehouli","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1136\/ijgc-2020-001950_bb0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/ijgc-2019-000976","article-title":"Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer","volume":"30","author":"Grabowski","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-001950_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.31","article-title":"Significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"1","author":"Matsuo","year":"2012","journal-title":"Cancer Med"},{"key":"10.1136\/ijgc-2020-001950_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0000000000000240","article-title":"Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer","volume":"123","author":"Matsuo","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001950_bb0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ygyno.2014.12.006","article-title":"Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion","volume":"136","author":"Matsuo","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ygyno.2014.03.563","article-title":"Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma","volume":"133","author":"Matsuo","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jso.24801","article-title":"Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma","volume":"117","author":"Matsuo","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2003-41864","article-title":"[\"IMO\"--intraoperative mapping of ovarian cancer]","volume":"125","author":"Sehouli","year":"2003","journal-title":"Zentralbl Gynakol"},{"key":"10.1136\/ijgc-2020-001950_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"143 Suppl 2","author":"Berek","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001950_bb0130","author":"Kurman","year":"2014"},{"key":"10.1136\/ijgc-2020-001950_bb0135","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-001950_bb0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2020-001950_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00404-020-05580-9","article-title":"Does lymph node ratio have any prognostic significance in maximally cytoreduced node-positive low-grade serous ovarian carcinoma?","volume":"302","author":"Aslan","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2020-001950_bb0150","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N Engl J Med"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24026276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:26:48Z","timestamp":1753234008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24026276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1048891X24026276"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001950","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}